AstraZeneca plc (AZN) Declares Dividend Increase – GBX 133.60 Per Share
AstraZeneca plc (LON:AZN) announced a dividend on Friday, February 2nd, Upcoming.Co.Uk reports. Investors of record on Thursday, February 15th will be paid a dividend of GBX 133.60 ($1.85) per share by the biopharmaceutical company on Monday, March 19th. This represents a yield of 2.8%. The ex-dividend date of this dividend is Thursday, February 15th. This is a positive change from AstraZeneca’s previous dividend of $68.90. The official announcement can be accessed at this link.
Shares of AstraZeneca (AZN) opened at GBX 4,822 ($66.62) on Wednesday. The stock has a market cap of $60,820.00 and a price-to-earnings ratio of 2,819.88. AstraZeneca has a fifty-two week low of GBX 4,260 ($58.86) and a fifty-two week high of GBX 5,520 ($76.26).
In related news, insider Philip A. J. Broadley acquired 415 shares of the business’s stock in a transaction dated Friday, February 2nd. The stock was acquired at an average price of GBX 4,846 ($66.95) per share, with a total value of £20,110.90 ($27,785.16).
AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on discovery and development of products, which are then manufactured, marketed and sold. The Company focuses on three main therapy areas: Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience.
Receive News & Ratings for AstraZeneca Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstraZeneca and related companies with MarketBeat.com's FREE daily email newsletter.